Ulf Smith
Corresponding author: Ulf Smith
Name/email consistency: high
- The WNT Inhibitor Dickkopf 1 and Bone Morphogenetic Protein 4 Rescue Adipogenesis in Hypertrophic Obesity in Humans. Gustafson, B., Smith, U. Diabetes (2012)
- Antagonistic effects of thiazolidinediones and cytokines in lipotoxicity. Smith, U., Hammarstedt, A. Biochim. Biophys. Acta (2010)
- TCF7L2 and type 2 diabetes--we WNT to know. Smith, U. Diabetologia (2007)
- Pathogenesis and treatment of diabetic vascular disease - illustrated by two cases. Smith, U., Laakso, M., Eliasson, B., Wesslau, C., Borén, J., Wiklund, O., Attvall, S. J. Intern. Med. (2006)
- Impaired ('diabetic') insulin signaling and action occur in fat cells long before glucose intolerance--is insulin resistance initiated in the adipose tissue?. Smith, U. Int. J. Obes. Relat. Metab. Disord. (2002)
- Thiazolidinediones (PPARgamma agonists) but not PPARalpha agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytes. Smith, U., Gogg, S., Johansson, A., Olausson, T., Rotter, V., Svalstedt, B. FASEB J. (2001)
- PKB inhibition prevents the stimulatory effect of insulin on glucose transport and protein translocation but not the antilipolytic effect in rat adipocytes. Smith, U., Carvalho, E., Mosialou, E., Beguinot, F., Formisano, P., Rondinone, C. Biochem. Biophys. Res. Commun. (2000)









